Achiziția de vaccin hexavalent (DTPa-VPI-HiB-HB)

Summary

Romania's Ministry of Health is procuring a framework agreement for hexavalent vaccine (DTPa-VPI-HiB-HB) combining protection against diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b, and hepatitis B. The framework covers 1.3–1.8 million doses with an estimated value of 368.35 million RON (excluding VAT). Subsequent contracts will be awarded based on best value (price and delivery time), with the first contract for 390,000 doses due by 31 January 2027. Up to 7 suppliers may be selected.